Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial* - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial*

98

Citations

13

References

2003

Year

Eugene W. Monroe, Albert Finn, Piyush M. Patel, Robinson Guerrero, Paul H. Ratner, David I. Bernstein

Journal of the American Academy of Dermatology

Desloratadine 5Allergy MedicineMedicineClinical DermatologyDermatologyPharmacologyDrug AllergyChronic Idiopathic Urticaria

References

	Year	Citations

Page 1